Cite
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis.
MLA
Commons, Robert J., et al. “Effect of Primaquine Dose on the Risk of Recurrence in Patients with Uncomplicated Plasmodium Vivax: A Systematic Review and Individual Patient Data Meta-Analysis.” Lancet Infectious Diseases, vol. 24, no. 2, Feb. 2024, pp. 172–83. EBSCOhost, https://doi.org/10.1016/S1473-3099(23)00430-9.
APA
Commons, R. J., Rajasekhar, M., Edler, P., Abreha, T., Awab, G. R., Baird, J. K., Barber, B. E., Chu, C. S., Cui, L., Daher, A., Gonzalez-Ceron, L., Grigg, M. J., Hwang, J., Karunajeewa, H., Lacerda, M. V. G., Ladeia-Andrade, S., Lidia, K., Llanos-Cuentas, A., Longley, R. J., & Pereira, D. B. (2024). Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis. Lancet Infectious Diseases, 24(2), 172–183. https://doi.org/10.1016/S1473-3099(23)00430-9
Chicago
Commons, Robert J, Megha Rajasekhar, Peta Edler, Tesfay Abreha, Ghulam R Awab, J Kevin Baird, Bridget E Barber, et al. 2024. “Effect of Primaquine Dose on the Risk of Recurrence in Patients with Uncomplicated Plasmodium Vivax: A Systematic Review and Individual Patient Data Meta-Analysis.” Lancet Infectious Diseases 24 (2): 172–83. doi:10.1016/S1473-3099(23)00430-9.